RIL
ABEO icon

Rothschild Investment LLC’s Abeona Therapeutics ABEO Stock Holding History

Rothschild Investment LLC’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-400
Closed -$64K – 412
2017
Q2 		$64K Sell
400
-240
-38% -$32.7K 0.01% 454
2017
Q1 		$80K Sell
640
-60
-9% -$7.74K 0.01% 461
2016
Q4 		$85K Buy
700
+140
+25% +$21.9K 0.01% 447
2016
Q3 		$84K Buy
560
+160
+40% +$15.6K 0.01% 455
2016
Q2 		$24K Buy
+400
New +$27.3K ﹤0.01% 476

Other funds holding ABEO

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Rothschild Investment LLC's ABEO Position: Q3 2017 in Review

Rothschild Investment LLC sold out of Abeona Therapeutics (ABEO) in Q3 2017, closing a stake of 400 shares — an estimated $64K sold.

Rothschild Investment LLC first reported a position in ABEO in Q2 2016 and held it in 5 quarters. The position peaked at $85K in Q4 2016. 75 funds tracked by Wall St. Rank hold ABEO as of Q3 2017.

  • Rothschild Investment LLC reported no remaining Abeona Therapeutics position as of Q3 2017 after selling out during the quarter.
  • Rothschild Investment LLC sold 400 Abeona Therapeutics shares in Q3 2017, an estimated $64K.
  • Rothschild Investment LLC first reported a position in Abeona Therapeutics in Q2 2016 and held it in 5 quarters.
  • Rothschild Investment LLC's Abeona Therapeutics position peaked at $85K in Q4 2016.
  • 75 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2017.

Based on Rothschild Investment LLC's 13F filing for Q3 2017, filed 25 Oct 2017.